Credit Trends: U.S. Composite Credit Spreads Daily (June 9, 2011) Jun 11

  • ID: 1819134
  • June 2011
  • Region: United States
  • Standard & Poors
1 of 2

Standard & Poor's investment-grade composite spread widened by one basis point on Wednesday to 171 basis points (bps), and the speculative-grade composite spread widened by 10 bps to 536 bps. By rating, the 'AA', 'A', and 'BBB' spreads each expanded by one basis point, to 122 bps, 151 bps, and 201 bps, respectively. The 'BB' spread widened by 8 bps to 391 bps, 'B' expanded by 9 bps to 568 bps, and 'CCC' widened by 13 bps to 806 bps. By industry, financial institutions and banks each expanded by 2 bps, to 260 bps and 222 bps, respectively. Industrials widened by 4 bps to 263 bps, utilities expanded by one basis point to 176 bps, and telecommunications widened by 3...

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.